Business Segments · Segment Reporting, Other Segment Item, Amount
Biotechnology — Segment Reporting, Other Segment Item, Amount
Danaher Biotechnology — Segment Reporting, Other Segment Item, Amount decreased by 19.2% to $989M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 7.0%, from $924M to $989M. Over 3 years (FY 2022 to FY 2025), Biotechnology — Segment Reporting, Other Segment Item, Amount shows relatively stable performance with a -3.3% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityModerate
First reportedQ1 2022
Last reportedQ1 2026Apr 21, 2026
How to read this metric
High or rising levels may indicate operational inefficiencies or frequent restructuring activities.
Detailed definition
Captures miscellaneous operating items or adjustments specific to the biotechnology segment that do not fit into standar...
Peer comparison
Varies significantly by company; often found in segment reconciliation notes.
Metric ID:
dhr_segment_biotechnology_segment_reporting_other_segment_item_amountHistorical Data
17 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.19B | $1.19B | $1.19B | $1.19B | $1.05B | $1.05B | $1.05B | $1.05B | $939M | $1B | $1.01B | $1.11B | $924M | $1.05B | $1.09B | $1.22B | $989M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -11.9% | +0.0% | +0.0% | +0.0% | -10.2% | +6.7% | +0.7% | +10.0% | -16.8% | +14.0% | +3.6% | +12.2% | -19.2% |
| YoY Change | — | — | — | — | -11.9% | -11.9% | -11.9% | -11.9% | -10.2% | -4.2% | -3.5% | +6.1% | -1.6% | +5.1% | +8.1% | +10.3% | +7.0% |
Range$924M – $1.22B
CAGR-4.5%
Avg YoY Growth-2.3%
Median YoY Growth-3.5%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Danaher's biotechnology — segment reporting, other segment item, amount?
- Danaher (DHR) reported biotechnology — segment reporting, other segment item, amount of $989M in Q1 2026.
- How has Danaher's biotechnology — segment reporting, other segment item, amount changed year-over-year?
- Danaher's biotechnology — segment reporting, other segment item, amount increased by 7.0% year-over-year, from $924M to $989M.
- What is the long-term trend for Danaher's biotechnology — segment reporting, other segment item, amount?
- Over 3 years (2022 to 2025), Danaher's biotechnology — segment reporting, other segment item, amount has grown at a -3.3% compound annual growth rate (CAGR), from $4.75B to $4.29B.
- What does biotechnology — segment reporting, other segment item, amount mean?
- Other miscellaneous operating costs or adjustments specific to the biotechnology segment.